Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

GMS Hygiene and Infection Control is a leading open access journal dedicated to advancing knowledge and research in the fields of hygiene, infection control, and public health. Published by GERMAN MEDICAL SCIENCE-GMS, this journal has been offering unrestricted access to its rich repository of scholarly articles since 2013, making significant contributions to the global discourse on infection prevention and control strategies. With its commitment to promoting high-quality research, GMS Hygiene and Infection Control is a vital resource for researchers, healthcare professionals, and students engaged in the pursuit of best practices for improving health outcomes. The journal is built upon a foundation of rigorous peer review and aims to disseminate innovative findings that address current challenges in hygiene and infection control, thereby enhancing clinical practices and public health policies worldwide.

Infection Disease & Health, published by Elsevier Inc, serves as a premier interdisciplinary journal dedicated to advancing the fields of infectious diseases, public health, and nursing. With an impressive impact factor reflective of its rigorous scholarly contributions, the journal is currently indexed within the Q2 category in Infectious Diseases and Q1 in Nursing (miscellaneous) as of 2023, indicating its esteemed position in these areas. Launched in 2016, it has rapidly established itself as a valuable resource for researchers, clinicians, and students alike, emphasizing both original research and comprehensive reviews that address pressing health challenges. Authors and readers are encouraged to engage with a wealth of content that is meticulously curated to inform and inspire innovative practices within the health sector. While the journal is not an open-access platform, it offers various access options to enhance dissemination of knowledge. As the field of infectious diseases evolves, Infection Disease & Health remains at the forefront, fostering scholarly dialogue and contributing to the development of effective health strategies globally.

Journal of Infection and Public Health is a premier open-access journal published by ELSEVIER SCIENCE LONDON, dedicated to advancing knowledge in the fields of infectious diseases, public health, and environmental health. Since its inception in 2008, this esteemed journal has become a cornerstone of research dissemination, especially after transitioning to an open-access model in 2017, allowing wider accessibility to groundbreaking studies. With an impressive impact factor and ranking in the Q1 category for Infectious Diseases and Public Health as of 2023, the journal stands at the forefront of scientific inquiry, boasting a Scopus rank of #22 out of 665 in Public Health, underscoring its influence and reach in the academic community. Researchers, professionals, and students alike will find the journal's rich repository of peer-reviewed articles invaluable for ongoing education and practice in a rapidly evolving field. For contributing to the global understanding of health dynamics, Journal of Infection and Public Health is a vital resource, inviting scholars to explore, engage, and contribute to the crucial discussions shaping our world.

Microbial Drug Resistance, published by MARY ANN LIEBERT, INC, is a pivotal journal that explores the critical intersection of microbiology and pharmacology with a keen focus on antibiotic resistance and related issues. Since its inception in 1995, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for innovative studies that inform the global response to antimicrobial resistance. With a commendable position in the Category Quartiles, ranked Q2 in Medicine (miscellaneous) and Q2 in Pharmacology for 2023, it caters to a multidisciplinary audience by addressing the implications of microbial resistance within various medical contexts. Although currently non-Open Access, the journal allows subscribers and institutions to access high-quality, peer-reviewed research, directly impacting policy and practice in healthcare settings. Committed to advancing our understanding and combating the challenges posed by resistant microbes, Microbial Drug Resistance remains an essential publication in the fields of microbiology, immunology, and pharmacology.

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic resource in the field of infectious diseases and microbiology. With its ISSN 0891-5520 and E-ISSN 1557-9824, this esteemed journal has been at the forefront of disseminating critical research findings and clinical advancements since its inception in 1987. Known for its high impact, the journal ranks in the Q1 category for both Infectious Diseases and Medical Microbiology as of 2023, which underscores its significant contribution to advancing knowledge and practice in these vital areas. Researchers, practitioners, and students alike rely on its comprehensive yet concise reviews and original articles, ensuring they stay abreast of emerging trends and therapeutics in infectious disease management. Although it does not offer open access, the journal remains pivotal in enriching scholarly dialogue and influencing clinical practices in the United States and beyond. Explore this vital publication and join a community dedicated to excellence in infectious disease research.

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

The American Journal of Infection Control is a leading peer-reviewed publication dedicated to advancing the field of infection prevention and control. Published by Mosby-Elsevier, this journal has been a crucial resource since its inception in 1980, focusing on the intersection of infectious diseases, public health, and health policy. As of 2023, it holds an impressive Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health, while also achieving Q2 rankings in Epidemiology and Infectious Diseases. With an increasing impact factor and a strong reputation reflected in its Scopus rankings, the journal appeals to researchers, health professionals, and students committed to preventing the spread of infections and enhancing healthcare safety. Although it does not currently offer Open Access, the journal ensures broad dissemination of its vital research through various subscription options. By fostering interdisciplinary collaboration and evidence-based practices, the American Journal of Infection Control plays a pivotal role in shaping effective infection control policies and practices worldwide.